NCT03080207

Brief Summary

At the end of the study, comparative information about the effects of PRP, complex decongestive physiotherapy and low level laser on edema volume, range of motion, muscle strength, functional capacity and quality of life will be obtained in the treatment of patients with lower limb lymphedema. Since there is no study about this field in the literature, this study will provide new and valuable contributions about treatment of lower extremity lymphedema for the researchers and clinicians.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 17, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2017

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 15, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

March 19, 2019

Status Verified

March 1, 2019

Enrollment Period

7 months

First QC Date

March 5, 2017

Last Update Submit

March 15, 2019

Conditions

Keywords

Lower Extremity LymphedemaPhysiotherapyComplex Decongestive PhysiotherapyLow Level LaserPlatelet rich plasma

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life

    12 weeks

Secondary Outcomes (4)

  • Lower-extremity-circumference

    12 weeks

  • Numeric rating scale

    12 weeks

  • 6 minutes walking test

    12 weeks

  • Tissue dielectric constant Questionnaire

    12 weeks

Study Arms (3)

Platelets / Platelet Enriched Plasma Regard (PRP) Method

EXPERIMENTAL
Procedure: PRP method

Complex Decongestive Physiotherapy

EXPERIMENTAL
Procedure: Low Level Laser

Low Level Laser

EXPERIMENTAL
Procedure: Complex Decongestive Physiotherapy

Interventions

PRP methodPROCEDURE

It will first be placed on a 25 cc venous blood centrifuge in anticoagulated tubes containing acid citrate dextrose (ACD), and autologous venous blood will be centrifuged at 3200 rpm for 15 minutes. Using the PRP kit, the plasma rich in platelet volume of about 3 cc volume will be removed. This will be activated by the addition of platelet agonists such as thrombin, calcium gluconate or calcium chloride. Injections should be administered subcutaneously for 2-3 weeks, 3-4 times for inguinal, popliteal region and ankle for a total of 12 weeks. Also, all patients in this groups have received Complex Decongestive Physiotherapy (Manual lymph drainage (MLD), skin care, compression therapy and active therapeutic exercise).

Platelets / Platelet Enriched Plasma Regard (PRP) Method

Low Density Laser treatment will be applied for the first 4 weeks every 12 weeks, the remaining 8 weeks 2 days / week. A total of 9 regions (6 point inguinal region and 3 points popliteal region) are to be applied by applying the laser head close to the skin (20000 Hz, 1.5 J / cm2) with the laser device and the regions where lymph nodes and lymph pathways are dense. During the application, the patient will be in the supine position for the popliteal region, with the patient in the supine position for the inguinal region and the legs free in the abdomen.Also, all patients in this groups have received Complex Decongestive Physiotherapy (Manual lymph drainage (MLD), skin care, compression therapy and active therapeutic exercise).

Complex Decongestive Physiotherapy

Complex Decongestive Physiotherapy (CDP) consists of four basic components and two phases. Four basic components; Manual lymph drainage (MLD), skin care, compression therapy and therapeutic exercise. Phase I (intense phase): It is also referred to as the phase of reducing the remission. In this phase, skin care and compression bandages are renewed after daily MLD application. The patient is taught how to bandage on his own. (Phase I, 4 weeks) The duration of phase I may vary according to the patient. In Phase II, MLD can be administered 2 or 3 times per week depending on the needs of the individual. In this case, the patient is followed by home program. Our cases will be treated in Phase I every day for 12 weeks in total and 2 days / week in Phase II according to KBF phases. All patients in this group have received only Complex Decongestive Physiotherapy.

Low Level Laser

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having lower extremity lymphedema
  • To be older than 18 ages.

You may not qualify if:

  • Having received radiotherapy treatment in the last 6 months,
  • Having received physiotherapy treatment in the last 6 months,
  • General health status is not eligible for treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Faculty of Health Science

Istanbul, 34740, Turkey (Türkiye)

Location

Related Publications (1)

  • Akgul A, Tarakci E, Arman N, Civi T, Irmak S. A Randomized Controlled Trial Comparing Platelet-Rich Plasma, Low-Level Laser Therapy, and Complex Decongestive Physiotherapy in Patients with Lower Limb Lymphedema. Lymphat Res Biol. 2020 Oct;18(5):439-447. doi: 10.1089/lrb.2019.0064. Epub 2020 Feb 19.

MeSH Terms

Interventions

Low-Level Light Therapy

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Study Officials

  • Ahmet Akgul, Prof.Dr.

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Ela Tarakci, Assoc.Dr.

    Istanbul University

    STUDY DIRECTOR
  • Nilay Arman, PhD, PT

    Istanbul University

    STUDY DIRECTOR
  • Tugba Civi, PT

    Istanbul University

    STUDY DIRECTOR
  • Musa Cirak, MD, DR

    Bakirkoy Dr.Sadi Konuk Education and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.Dr.

Study Record Dates

First Submitted

March 5, 2017

First Posted

March 15, 2017

Study Start

January 17, 2017

Primary Completion

August 1, 2017

Study Completion

January 1, 2018

Last Updated

March 19, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations